When Lourdes Colon refused chemotherapy for Stage III Hodgkin's lymphoma and began documenting her recovery on camera, she discovered something that overturned one of her oncologist's foundational recommendations. The PET-CT scan she had undergone used radioactive glucose to locate her tumours. Her lymphoma was in her lymphatic system and therefore visible on the surface of her body. In the days after the scan, she watched a visible mass grow out of her armpit. The glucose injection had fed the cancer for far longer than the forty-five minute clearance window her doctors had described. She filmed the growth, the shrinkage that followed her detoxification protocol, and the full recovery. She created a documentary called Create Option C that stands as one of the more rigorously self-documented cancer recoveries in the public record. Her story is one of 117 expert and patient accounts gathered across the knowledge base this post draws from.
- Cancer cells are metabolically locked into glucose fermentation and cannot switch fuel sources. Sugar restriction is a targeted clinical intervention, not a wellness preference.
- Proteolytic enzymes taken between meals circulate in the bloodstream and strip the fibrin coatings that cancer cells use to hide from immune recognition. One patient survived pancreatic cancer for over thirty years on this protocol.
- Adrenaline activates specific receptors on cancer cells that trigger treatment-resistance pathways. The fear generated by a terminal prognosis measurably worsens treatment outcomes at the biochemical level.
- Heavy metals, glyphosate, root canal infections, and chronic stress each compromise the immune environment in ways that must be addressed before treatment can hold.
- Every patient recovery documented in this series involved a decision to address the full biological terrain rather than the tumour alone.
Why fear makes cancer harder to treat
A 2009 Chinese study documented a mechanism that reframes the entire patient experience of diagnosis: adrenaline, the hormone the body produces under fear, activates beta-adrenergic receptors on the surface of cancer cells. When those receptors are activated, they trigger intracellular survival pathways that make cancer cells more resistant to any treatment being applied. The more frightened the patient, the more adrenaline circulates, and the harder their cancer becomes to treat at the biochemical level.
Dr Joan Borysenko, a Harvard-trained scientist and psychologist, explained the second mechanism to health journalist Laura Bond: stress hormones damage the enzymes responsible for repairing breaks in DNA. These repair enzymes are the body's primary defence against the accumulated genetic damage that drives cancer progression. Chronic fear does not just suppress the immune system in a general sense. It specifically disables the molecular machinery that catches and corrects the mutations cancer depends on.
The practical implication, drawn from the practitioners in this knowledge base, is that the standard oncology encounter is not a neutral information exchange. A brief appointment, a frightening prognosis, an immediate recommendation to begin chemotherapy: It is a biological event that activates the sympathetic nervous system, floods the body with treatment-resistance hormones, and redirects energy away from the immune response at precisely the moment the patient most needs it.
The fibrin problem: why cancer hides from your immune system
One of the most consistently overlooked mechanisms in cancer biology is the fibrin coating surrounding tumour cells. Fibrin is the protein the body uses in blood clotting and wound repair. Cancer cells hijack this system, surrounding themselves with a fibrin shell that makes them appear to natural killer cells and T-cells as damaged tissue under repair rather than as foreign threats requiring elimination. The immune system, operating as designed, passes them by.
Scottish embryologist John Beard described this mechanism in 1902 in his trophoblast theory of cancer. Proteolytic enzymes taken between meals have no food protein to digest. They circulate systemically and break down this fibrin coating. Once the coating is removed, the cancer cell surface antigens become visible to the immune cells that were always equipped to recognise and destroy them. Dr Nicholas Gonzalez brought this protocol into modern clinical practice. Among his documented patients is someone who survived pancreatic adenocarcinoma for over thirty years. Pancreatic cancer carries the worst prognosis in conventional oncology, with typical survival measured in months. The enzyme protocol is the constant across his long-term survivors.
Laura Bond, whose mother came to Dr Gonzalez after a Stage IV pancreatic adenocarcinoma diagnosis and was still hiking in Romania eighteen months later, adds a second mechanism from Dr Gary Gordon: enzymes reduce blood viscosity, making blood less thick and reducing the mobility of metastatic cancer cells through the bloodstream. The most common proximate cause of cancer death is not the primary tumour but metastasis. An intervention that both exposes cancer cells to immune recognition and reduces the efficiency of their spread addresses two of the most critical failure points simultaneously.
What Lourdes Colon's PET-CT experiment revealed
Lourdes Colon's case is unusual in cancer medicine because her Hodgkin's lymphoma was in her lymphatic system and therefore externally visible. This gave her the ability to observe in real time what PET-CT scans do to tumours. The scan uses radioactive glucose to locate cancer cells because cancer cells take up glucose at a much higher rate than surrounding tissue. Colon documented that in the days after her scan, a mass visibly grew out of her armpit. The glucose injection had fed tumour growth well past the forty-five minute clearance window her physicians had cited.
She filmed the response and the reversal. Wheat grass applied directly to the surface tumour for an hour at a time produced measurable shrinkage. Daily colonics began clearing the radioactive dye and toxic burden that had accumulated. Coffee enemas supported liver detoxification. A complete elimination of sugar and animal products removed the primary fuel source the cancer depended on. The pressure that had prevented her from lying on her right side resolved over weeks. She documented each stage on camera because she wanted other patients to have what she had not: visual evidence that the reversal was real and that the mechanism was comprehensible.
The terrain: what every practitioner in this series addresses first
No practitioner in this knowledge base treats the tumour in isolation. Every protocol begins with an assessment of the terrain in which the cancer developed. The specific terrain factors they identify and test for overlap consistently: heavy metal accumulation (particularly mercury from dental amalgam and lead from environmental exposure), glyphosate from food and water, root canal infections (Dr Thomas Rau of the Paracelsus Clinic in Switzerland documented that 99 percent of his breast and ovarian cancer patients had a root canal on the same meridian as their tumour), fluoride and bromide displacing iodine in thyroid and breast tissue, and chronic electromagnetic field exposure.
Jeffrey Smith of the Institute for Responsible Technology documents the glyphosate contribution with molecular specificity. Glyphosate destroys the gut bacteria that produce essential amino acids and anti-cancer compounds. It increases intestinal permeability through zonulin upregulation. It blocks the CYP enzyme family the liver uses to neutralise carcinogens. And it chelates zinc, which is required for DNA repair. Removing this exposure is a clinical requirement in serious terrain restoration, not a lifestyle consideration.
What the long-term survivors share
The recovery accounts in this knowledge base span cancer types, nationalities, and decades. Bond's mother reversed ovarian, uterine, and Stage IV pancreatic cancer. Colon reversed Stage III Hodgkin's lymphoma. Olivia Newton-John managed multiple cancer recurrences through Amazon botanicals, cannabis, and dietary intervention while maintaining an active international performing career. Pamela Kelsey was told she had terminal pancreatic cancer in the 1970s and was still alive at the time of filming. The Hoxsey Bio-Medical Center in Tijuana, operating since the 1940s on a botanical formula first observed when a horse grazed itself back to health, reports documented cure rates that conventional oncology has consistently refused to evaluate.
What these patients share is not a protocol. It is a decision architecture: refuse passive acceptance of a terminal prognosis, investigate the full range of available evidence before committing to a treatment path, address every dimension of the biological terrain rather than the tumour alone, and maintain the chosen approach through the months and years required for genuine biological restoration. Every practitioner interviewed across 117 expert sessions identifies this orientation as a clinical factor in the outcomes they observe. The biology of survivorship, they argue, is not separate from the psychology of survivorship. They are the same thing.
Going deeper
The full 117-interview knowledge base behind this post is available to query on tryit.tv. Rather than reading through hundreds of thousands of words of clinical testimony, you can ask a specific question about your situation and get a direct answer drawn from the relevant practitioners and patient accounts. If you have a specific cancer type, a specific treatment decision, or a specific protocol you want to understand in more depth, chat with the full document and get a personalised answer in seconds.